Janney Montgomery Scott LLC Has $568,000 Stock Position in HealthEquity, Inc. $HQY

Janney Montgomery Scott LLC lowered its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 13.7% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 5,418 shares of the company’s stock after selling 858 shares during the quarter. Janney Montgomery Scott LLC’s holdings in HealthEquity were worth $568,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in HQY. Invesco Ltd. grew its position in HealthEquity by 50.6% during the first quarter. Invesco Ltd. now owns 2,446,198 shares of the company’s stock worth $216,171,000 after buying an additional 821,425 shares in the last quarter. Goldman Sachs Group Inc. raised its holdings in HealthEquity by 1.4% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,133,166 shares of the company’s stock valued at $100,138,000 after acquiring an additional 15,458 shares in the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of HealthEquity by 1.3% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,100,970 shares of the company’s stock worth $97,293,000 after purchasing an additional 14,159 shares in the last quarter. Stephens Investment Management Group LLC grew its holdings in shares of HealthEquity by 1.8% during the 1st quarter. Stephens Investment Management Group LLC now owns 1,069,446 shares of the company’s stock worth $94,507,000 after purchasing an additional 19,009 shares in the last quarter. Finally, Wellington Management Group LLP grew its holdings in shares of HealthEquity by 24.9% during the 1st quarter. Wellington Management Group LLP now owns 848,940 shares of the company’s stock worth $75,021,000 after purchasing an additional 169,337 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

Insiders Place Their Bets

In other HealthEquity news, EVP Delano Ladd sold 6,000 shares of the firm’s stock in a transaction dated Friday, September 19th. The shares were sold at an average price of $94.11, for a total value of $564,660.00. Following the completion of the sale, the executive vice president owned 79,456 shares in the company, valued at approximately $7,477,604.16. This trade represents a 7.02% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Michael Henry Fiore sold 1,781 shares of the firm’s stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total transaction of $157,102.01. Following the completion of the sale, the executive vice president owned 49,795 shares of the company’s stock, valued at $4,392,416.95. The trade was a 3.45% decrease in their position. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by insiders.

HealthEquity Stock Performance

NASDAQ HQY opened at $91.04 on Friday. The firm has a market cap of $7.84 billion, a price-to-earnings ratio of 55.18, a PEG ratio of 1.33 and a beta of 0.47. The company has a 50 day moving average of $91.73 and a 200-day moving average of $93.96. The company has a current ratio of 4.23, a quick ratio of 4.23 and a debt-to-equity ratio of 0.47. HealthEquity, Inc. has a 1-year low of $74.07 and a 1-year high of $116.65.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, September 2nd. The company reported $0.92 EPS for the quarter, hitting analysts’ consensus estimates of $0.92. The business had revenue of $325.80 million for the quarter, compared to analyst estimates of $320.68 million. HealthEquity had a return on equity of 12.04% and a net margin of 11.49%. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. On average, equities analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages recently commented on HQY. Royal Bank Of Canada upped their target price on HealthEquity from $109.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, September 3rd. KeyCorp decreased their target price on shares of HealthEquity from $125.00 to $120.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 8th. Weiss Ratings reiterated a “hold (c+)” rating on shares of HealthEquity in a research report on Wednesday, October 8th. Jefferies Financial Group lifted their target price on shares of HealthEquity from $130.00 to $134.00 and gave the company a “buy” rating in a research report on Wednesday, September 3rd. Finally, Raymond James Financial restated a “strong-buy” rating and set a $120.00 price target (up previously from $115.00) on shares of HealthEquity in a research note on Tuesday, July 8th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, HealthEquity has a consensus rating of “Moderate Buy” and an average target price of $121.31.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.